335 related articles for article (PubMed ID: 18006561)
1. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
Fauser BC; Diedrich K; Devroey P;
Hum Reprod Update; 2008; 14(1):1-14. PubMed ID: 18006561
[TBL] [Abstract][Full Text] [Related]
2. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
3. What role of estrogens in ovarian stimulation.
Laven JS; Fauser BC
Maturitas; 2006 Jul; 54(4):356-62. PubMed ID: 16782289
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with oral contraceptives in infertile anovulatory patients with polycystic ovary syndrome who receive gonadotropins for controlled ovarian stimulation.
Palomba S; Falbo A; Orio F; Russo T; Tolino A; Zullo F
Fertil Steril; 2008 Jun; 89(6):1838-42. PubMed ID: 17980363
[TBL] [Abstract][Full Text] [Related]
5. [Induction of monofollicular cycles].
Vegetti W; Guermandi E; Baroni E; Alagna F; Riccaboni A; Nicolosi AE; Calanna G; Ragni G; Crosignani PG
Minerva Ginecol; 2001 Feb; 53(1):41-8. PubMed ID: 11279395
[TBL] [Abstract][Full Text] [Related]
6. Can anti-Müllerian hormone concentrations be used to determine gonadotrophin dose and treatment protocol for ovarian stimulation?
Fleming R; Broekmans F; Calhaz-Jorge C; Dracea L; Alexander H; Nyboe Andersen A; Blockeel C; Jenkins J; Lunenfeld B; Platteau P; Smitz J; de Ziegler D
Reprod Biomed Online; 2013 May; 26(5):431-9. PubMed ID: 23507133
[TBL] [Abstract][Full Text] [Related]
7. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
[TBL] [Abstract][Full Text] [Related]
8. [Poor ovary response to the controlled ovarian hyperstimulation].
Vladimirov IaK; Blagoeva V
Akush Ginekol (Sofiia); 2003; 42(6):25-8. PubMed ID: 15067811
[TBL] [Abstract][Full Text] [Related]
9. Why does ovarian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome.
Hendriks ML; Ket JC; Hompes PG; Homburg R; Lambalk CB
Hum Reprod Update; 2007; 13(3):249-64. PubMed ID: 17208949
[TBL] [Abstract][Full Text] [Related]
10. Consensus on infertility treatment related to polycystic ovary syndrome.
Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
Hum Reprod; 2008 Mar; 23(3):462-77. PubMed ID: 18308833
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in ovarian stimulation--current concepts.
Loutradis D; Vlismas A; Drakakis P; Antsaklis A
Ann N Y Acad Sci; 2008 Apr; 1127():10-9. PubMed ID: 18443324
[TBL] [Abstract][Full Text] [Related]
12. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
[TBL] [Abstract][Full Text] [Related]
13. Modern trends in ovulation induction.
Vyjayanthi S; Glanville J; Yasmin E; Balen AH
Hum Fertil (Camb); 2007 Jun; 10(2):117-21. PubMed ID: 17564892
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS).
Morón FJ; de Castro F; Royo JL; Montoro L; Mira E; Sáez ME; Real LM; González A; Mañes S; Ruiz A
Pharmacogenet Genomics; 2006 Jul; 16(7):485-95. PubMed ID: 16788381
[TBL] [Abstract][Full Text] [Related]
15. [Pituitary down-regulation and ovulation stimulation with gradually increased gonadotropin in controlled ovarian hyperstimulation].
Zhu L; Song YL; Cui YG; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):361-3. PubMed ID: 17425993
[TBL] [Abstract][Full Text] [Related]
16. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?
Altmäe S; Hovatta O; Stavreus-Evers A; Salumets A
Hum Reprod Update; 2011; 17(6):813-28. PubMed ID: 21862569
[TBL] [Abstract][Full Text] [Related]
17. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome.
Overbeek A; Kuijper EA; Hendriks ML; Blankenstein MA; Ketel IJ; Twisk JW; Hompes PG; Homburg R; Lambalk CB
Hum Reprod; 2009 Aug; 24(8):2007-13. PubMed ID: 19401323
[TBL] [Abstract][Full Text] [Related]
18. Ovarian hyperstimulation syndrome: definition, incidence, and classification.
Zivi E; Simon A; Laufer N
Semin Reprod Med; 2010 Nov; 28(6):441-7. PubMed ID: 21082501
[TBL] [Abstract][Full Text] [Related]
19. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.
Mathur R; Kailasam C; Jenkins J
Hum Fertil (Camb); 2007 Jun; 10(2):75-85. PubMed ID: 17564886
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphisms in the FSH receptor gene and ovarian performance: future role in IVF.
Mohiyiddeen L; Nardo LG
Hum Fertil (Camb); 2010; 13(2):72-8. PubMed ID: 20184506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
